Affiliation:
1. National Medical Research Center for Therapy and Preventive Medicine;
Sklifosovsky Research Institute of Emergency Medicine
2. National Medical Research Center for Therapy and Preventive Medicine
3. Sklifosovsky Research Institute of Emergency Medicine
Abstract
Atrial fibrillation (AF) after coronary bypass surgery is recorded in 20- 60% of patients and increase the early and long-term postoperative mortality. The aim of the review is to analyze the studies on causal relationships between damaging factors and the development of myocardial inflammation at each stage of surgical treatment in patients with multivessel coronary artery disease. In the review, myocardial inflammation is considered from the point of view of a continuum — a chronic process that originates from the coronary endothelium damage and continuously proceeds within the AF pathogenesis after coronary bypass surgery. For the first time, the concept of inflammatory continuum for postoperative AF is introduced. The review discusses the main and latest laboratory and instrumental markers of local and systemic inflammatory response, which are informative in terms of severity and promising for improving approaches to the diagnosis and prevention of postoperative AF. The review was prepared using available materials from Russian and foreign library databases (PubMed, Medline, Web of Science and Cochrane Library). The search depth was >25 years since 1996. Based on the analysis of available studies, we concluded that inflammation is not just evidence of AF, but plays a causal role in its pathogenesis at each stage of surgical myocardial revascularization.
Subject
Cardiology and Cardiovascular Medicine
Reference42 articles.
1. Petrakova ES, Savina NM, Molochkov AV. Atrial Fibrillation After Coronary Artery Bypass Surgery: Risk Factors, Prevention and Treatment. Kardiologiia. 2020;60(9):134-48. (In Russ.) doi:10.18087/cardio.2020.9.n1074.
2. Kirichenko AA. Anti-inflammatory therapy in atherosclerosis — is it a new promising trend? Consilium Medicum. 2018;20(5):18-22. (In Russ.) doi:10.26442/2075-1753_2018.5.18-22.
3. Sergienko IV, Ansheles AA, Kukharchuk VV. Dyslipidemias, atherosclerosis and coronary heart disease: modern aspects of pathogenesis, diagnosis and treatment. Moscow: Publishing house LLC “PatiSS”, 2020. р. 295. (In Russ.) ISBN: 978-5-90363-366-1.
4. Ridker PM, Everett BM, Thuren T, et al. CANTOS Trial Group. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. N Engl J Med. 2017;377(12):1119-31. doi:10.1056/NEJMoa1707914.
5. Nasonov EL, Popkova TV. Role of interleukin 1 in the development of atherosclerosis. Rheumatology Science and Practice. 2018;56:28-34. (In Russ.) doi:10.14412/1995-4484-2018-28-34.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献